Journal
ONCOGENE
Volume 20, Issue 30, Pages 4029-4040Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.onc.1204565
Keywords
insulin-like growth factors; IGF receptor; Atm; melanoma; radiosensitivity
Funding
- NINDS NIH HHS [R01 NS31763] Funding Source: Medline
Ask authors/readers for more resources
The type 1 insulin-like growth factor receptor (IGF1R) is required for growth, tumorigenicity and protection from apoptosis, IGF1R overexpression is associated with radioresistance in breast cancer. We used antisense (AS) RNA to downregulate IGF1R expression in mouse melanoma cells. Cells expressing AS-IGF1R transcripts were more radiosensitive in vitro and in vivo than controls. Also they showed reduced radiation-induced p53 accumulation and p53 serine 18 phosphorylation, and radioresistant DNA synthesis. These changes were reminiscent of the cellular phenotype of the human genetic disorder ataxia-telangiectasia (A-T), caused by mutations in the A TM gene. Cellular Atm protein levels mere lower in AS-IGF1R-transfected cells than in control cells, although there was no difference in Atm expression at,the transcriptional level. AS-IGF1R cells had detectable basal Atm kinase activity, but failed to induce kinase activity after irradiation. This suggests that IGF1R signalling can modulate the function of Atm, and supports the concept of targeted IGF1R downregulation as a potential treatment for malignant melanoma and other radioresistant tumours.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available